Acutus Medical Inc. (AFIB) NASDAQ
$0.17 - (-)
Market Cap: $5.02M
As of 04/23/24 12:00 AM EDT. Market open.
Acutus Medical Inc. (AFIB)
NASDAQ
$0.17
- (-)
Market Cap: $5.02M
As of 04/23/24 12:00 AM EDT. Market open.
Add to Portfolio
world class talent with the mission to reshape ep acutus medical has attracted some of the most respected pioneers and leaders in electrophysiology and cardiac device manufacturing to join our organization and our worldwide network of collaborative partners. the common bond that brings us together is our passion and collective capability to revolutionize a field that has not seen major ... read more
COMPANY PROFILE
Sector
Manufacturing
Industry
Surgical and Medical Instrument Manufacturing
Sector
Manufacturing
Industry
Surgical and Medical Instrument Manufacturing
Full Time Employees
210
Address
.
PRICE CHART FOR ACUTUS MEDICAL INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$0.17
Days Range
$0.17 - $0.17
52 week range
$0.16 - $1.09
Volume
26,251
Avg. Volume (30 days)
423,322
Market Cap
$5.02M
Dividend Yield
-
P/E
(0.06)
Shares Outstanding
29,715,962
Open
-
Previous Close
$0.17
Days Range
$0.17 - $0.17
52 week range
$0.16 - $1.09
Volume
26,251
Avg. Volume (30 days)
423,322
Market Cap
$5.02M
Dividend Yield
-
P/E
(0.06)
Shares Outstanding
29,715,962
FINANCIAL STATEMENTS FOR ACUTUS MEDICAL INC
LOADING...
INSIDER TRANSACTIONS FOR ACUTUS MEDICAL INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Sohn Tom | SVP, Gen. Counsel & Secretary | Feb 06, 2024 | Option Exercise | $0.17 | 7,582 | 1,312 | 105,009 | Feb 07, 2024, 04:12 PM |
Mukai Takeo | CFO | Feb 01, 2024 | Option Exercise | $0.19 | 2,869 | 548 | 81,349 | Feb 02, 2024, 04:06 PM |
Sohn Tom | SVP, Gen. Counsel & Secretary | Feb 01, 2024 | Option Exercise | $0.19 | 5,709 | 1,090 | 112,591 | Feb 02, 2024, 04:05 PM |
Mathews Kevin | SVP, Commercial | Jan 07, 2024 | Option Exercise | $0.19 | 6,342 | 1,199 | 61,106 | Jan 18, 2024, 04:10 PM |
Roman David | President & CEO | Jan 07, 2024 | Option Exercise | $0.19 | 24,086 | 4,552 | 332,134 | Jan 18, 2024, 04:10 PM |
Mukai Takeo | CFO | Sep 01, 2023 | Option Exercise | $0.49 | 1,729 | 844 | 84,218 | Sep 05, 2023, 04:24 PM |
Sohn Tom | SVP, Gen. Counsel & Secretary | Aug 05, 2023 | Option Exercise | $0.69 | 433 | 299 | 118,300 | Aug 07, 2023, 05:50 PM |
Mathews Kevin | SVP, Commercial | Aug 05, 2023 | Option Exercise | $0.69 | 134 | 92 | 67,448 | Aug 07, 2023, 05:50 PM |
Roman David | President & CEO | Jun 01, 2023 | Option Exercise | $0.85 | 17,290 | 14,660 | 362,704 | Jun 01, 2023, 07:28 PM |
Roman David | President & CEO | Apr 01, 2023 | Option Exercise | $0.75 | 3,165 | 2,386 | 379,994 | Apr 04, 2023, 04:19 PM |
Mukai Takeo | CFO | Feb 01, 2023 | Option Exercise | $1.87 | 2,855 | 5,339 | 36,448 | Feb 02, 2023, 05:10 PM |
Roman David | President & CEO | Feb 01, 2023 | Option Exercise | $1.87 | 10,196 | 19,067 | 248,159 | Feb 02, 2023, 05:09 PM |
Piscitello Charlie | SVP, Chief People Officer | Feb 01, 2023 | Option Exercise | $1.87 | 6,627 | 12,392 | 44,038 | Feb 02, 2023, 05:09 PM |
Mathews Kevin | SVP, Commercial | Feb 01, 2023 | Option Exercise | $1.87 | 3,540 | 6,620 | 24,153 | Feb 02, 2023, 05:08 PM |
Sohn Tom | SVP, Gen. Counsel & Secretary | Feb 01, 2023 | Option Exercise | $1.87 | 6,525 | 12,202 | 57,190 | Feb 02, 2023, 05:08 PM |
Piscitello Charlie | Chief People Officer | Aug 05, 2022 | Option Exercise | $1.56 | 433 | 675 | 49,415 | Aug 09, 2022, 04:18 PM |
Sohn Tom | SVP, Gen. Counsel & Secretary | Aug 05, 2022 | Option Exercise | $1.56 | 433 | 675 | 63,613 | Aug 09, 2022, 04:17 PM |
Mathews Kevin | SVP, Global Sales | Aug 05, 2022 | Option Exercise | $1.56 | 134 | 209 | 27,693 | Aug 09, 2022, 04:16 PM |
Huennekens R Scott | Director | Jun 03, 2022 | Sale | $0.58 | 60,000 | 34,800 | 507,509 | Jun 03, 2022, 07:35 PM |
Burgess Vincent J | Chief Executive Officer | Apr 01, 2022 | Option Exercise | $1.30 | 3,896 | 5,065 | 61,469 | Apr 05, 2022, 04:06 PM |
McQuillan Steven | SVP, Clinical Affairs & QA | Apr 01, 2022 | Option Exercise | $1.30 | 733 | 953 | 45,844 | Apr 05, 2022, 04:04 PM |
Hinrichs James F. | Director | Nov 15, 2021 | Buy | $3.78 | 40,000 | 151,220 | 52,911 | Nov 17, 2021, 04:45 PM |
McQuillan Steven | SVP, Clinical Affairs & QA | Aug 05, 2021 | Option Exercise | $15.52 | 305 | 4,734 | 14,577 | Aug 27, 2021, 04:28 PM |
Burgess Vincent J | Chief Executive Officer | Aug 05, 2021 | Option Exercise | $15.52 | 1,922 | 29,829 | 65,365 | Aug 27, 2021, 04:26 PM |
ORBIMED ADVISORS LLC | Director | Jul 19, 2021 | Buy | $14.00 | 1,071,428 | 14,999,992 | 4,872,025 | Jul 21, 2021, 05:30 PM |
Bonita David P | Director | Jul 19, 2021 | Buy | $14.00 | 1,071,428 | 14,999,992 | 4,872,025 | Jul 21, 2021, 05:24 PM |
Flynn James E | Director | Jul 19, 2021 | Buy | $14.00 | 680,592 | 9,528,288 | 3,438,589 | Jul 21, 2021, 05:14 PM |
Flynn James E | Director | Jul 19, 2021 | Buy | $14.00 | 390,836 | 5,471,704 | 1,974,638 | Jul 21, 2021, 05:14 PM |
Barnickel John | Chief Commercial Officer | Aug 10, 2020 | Buy | $18.00 | 7,300 | 131,400 | 13,966 | Aug 12, 2020, 09:47 PM |
Hinrichs James F. | Director | Aug 10, 2020 | Buy | $18.00 | 10,000 | 180,000 | 11,111 | Aug 12, 2020, 09:47 PM |
Bonita David P | Director | Aug 10, 2020 | Buy | $18.00 | 415,000 | 7,470,000 | 373,500 | Aug 12, 2020, 09:06 PM |
ORBIMED ADVISORS LLC | Director | Aug 10, 2020 | Buy | $18.00 | 415,000 | 7,470,000 | 373,500 | Aug 12, 2020, 09:06 PM |
Flynn James E | Director | Aug 10, 2020 | Buy | $18.00 | 555,556 | 10,000,008 | 2,758,000 | Aug 12, 2020, 04:26 PM |
Flynn James E | Director | Aug 10, 2020 | Buy | $18.00 | 944,444 | 16,999,992 | 1,583,802 | Aug 12, 2020, 04:26 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Sohn Tom | SVP, Gen. Counsel & Secretary | 02/06/2024 | 1,312 |
Mukai Takeo | CFO | 02/01/2024 | 548 |
Sohn Tom | SVP, Gen. Counsel & Secretary | 02/01/2024 | 1,090 |
Mathews Kevin | SVP, Commercial | 01/07/2024 | 1,199 |
Roman David | President & CEO | 01/07/2024 | 4,552 |
Mukai Takeo | CFO | 09/01/2023 | 844 |
Sohn Tom | SVP, Gen. Counsel & Secretary | 08/05/2023 | 299 |
Mathews Kevin | SVP, Commercial | 08/05/2023 | 92 |
Roman David | President & CEO | 06/01/2023 | 14,660 |
Roman David | President & CEO | 04/01/2023 | 2,386 |
Mukai Takeo | CFO | 02/01/2023 | 5,339 |
Roman David | President & CEO | 02/01/2023 | 19,067 |
Piscitello Charlie | SVP, Chief People Officer | 02/01/2023 | 12,392 |
Mathews Kevin | SVP, Commercial | 02/01/2023 | 6,620 |
Sohn Tom | SVP, Gen. Counsel & Secretary | 02/01/2023 | 12,202 |
Piscitello Charlie | Chief People Officer | 08/05/2022 | 675 |
Sohn Tom | SVP, Gen. Counsel & Secretary | 08/05/2022 | 675 |
Mathews Kevin | SVP, Global Sales | 08/05/2022 | 209 |
Huennekens R Scott | Director | 06/03/2022 | 34,800 |
Burgess Vincent J | Chief Executive Officer | 04/01/2022 | 5,065 |
McQuillan Steven | SVP, Clinical Affairs & QA | 04/01/2022 | 953 |
Hinrichs James F. | Director | 11/15/2021 | 151,220 |
McQuillan Steven | SVP, Clinical Affairs & QA | 08/05/2021 | 4,734 |
Burgess Vincent J | Chief Executive Officer | 08/05/2021 | 29,829 |
ORBIMED ADVISORS LLC | Director | 07/19/2021 | 14,999,992 |
Bonita David P | Director | 07/19/2021 | 14,999,992 |
Flynn James E | Director | 07/19/2021 | 9,528,288 |
Flynn James E | Director | 07/19/2021 | 5,471,704 |
Barnickel John | Chief Commercial Officer | 08/10/2020 | 131,400 |
Hinrichs James F. | Director | 08/10/2020 | 180,000 |
Bonita David P | Director | 08/10/2020 | 7,470,000 |
ORBIMED ADVISORS LLC | Director | 08/10/2020 | 7,470,000 |
Flynn James E | Director | 08/10/2020 | 10,000,008 |
Flynn James E | Director | 08/10/2020 | 16,999,992 |
Load More Insider Transactions
FUNDS WITH A POSITION IN ACUTUS MEDICAL INC
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,660,808 | 0.00992% | No change | Other |
ORBIMED ADVISORS LLC | 2,648,386 | 0.01% | No change | Other |
RENAISSANCE TECHNOLOGIES LLC | 327,000 | 0.0001% | 3.68% | Other |
BLACKROCK INC. | 206,681 | 0% | No change | Other |
GEODE CAPITAL MANAGEMENT, LLC | 206,624 | 0% | No change | Other |
BUYBACK ANNOUNCEMENT(S) FOR ACUTUS MEDICAL INC
LOADING...